These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29133776)

  • 1. Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients.
    Fox BD; Ashquar F; Raviv Y; Rozengarten D; Straichman O; Izhakian S; Kramer MR
    Ann Transplant; 2017 Nov; 22():677-681. PubMed ID: 29133776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation.
    Lichtenberg S; Rahamimov R; Green H; Fox BD; Mor E; Gafter U; Chagnac A; Rozen-Zvi B
    Eur J Clin Pharmacol; 2017 Jul; 73(7):819-826. PubMed ID: 28342067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
    Ollech JE; Kramer MR; Peled N; Ollech A; Amital A; Medalion B; Saute M; Shitrit D
    Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-Release Tacrolimus Stabilizes Decline of Forced Expiratory Volume in 1 Second Through Decreasing Fluctuation of Its Trough Blood Level.
    Matsuda Y; Eba S; Hoshi F; Oishi H; Sado T; Noda M; Sakurada A; Watanabe T; Niikawa H; Akiba M; Okada Y
    Transplant Proc; 2018 Nov; 50(9):2768-2770. PubMed ID: 30401394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations.
    Bonatti H; Barroso LF; Sawyer RG; Kotton CN; Sifri CD
    Transpl Infect Dis; 2012 Dec; 14(6):635-48. PubMed ID: 22340660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.
    Rivosecchi RM; Clancy CJ; Shields RK; Ensor CR; Shullo MA; Falcione BA; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation.
    Thölking G; Siats L; Fortmann C; Koch R; Hüsing A; Cicinnati VR; Gerth HU; Wolters HH; Anthoni C; Pavenstädt H; Suwelack B; Schmidt HH; Kabar I
    Ann Transplant; 2016 Mar; 21():167-79. PubMed ID: 27003330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Spectrum of Malignant Neoplasms among Liver Transplant Recipients: Sociodemographic Factors, Mortality, and Hospital Burden.
    Haider M; Bapatla A; Ismail R; Chaudhary AJ; Iqbal S; Haider SM
    Int J Med Sci; 2022; 19(2):299-309. PubMed ID: 35165515
    [No Abstract]   [Full Text] [Related]  

  • 12. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients.
    Kolaitis NA; Calabrese DR; Ahearn P; Venado A; Florez R; Lei HL; Isaak K; Henricksen E; Martinez E; Chong T; Shah RJ; Leard LE; Kleinhenz ME; Golden J; De Marco T; Greenland JR; Kukreja J; Hays SR; Blanc PD; Singer JP
    Am J Health Syst Pharm; 2019 Dec; 76(24):2019-2027. PubMed ID: 31696925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
    Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
    J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Skin Cancer Incidence in Caucasian and Non-Caucasian Liver Vs. Lung Transplant Recipients: A Tale of Two Regimens.
    Cohen BE; Krivitskiy I; Bui S; Forrester K; Kahn J; Barbers R; Ngo B
    Clin Drug Investig; 2019 Feb; 39(2):197-203. PubMed ID: 30471069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature.
    Bennett D; Fossi A; Refini RM; Gentili F; Luzzi L; Voltolini L; Paladini P; Mazzei MA; Rottoli P
    Tumori; 2016 Dec; 102(6):574-581. PubMed ID: 27647228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.